Globeflex Capital’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-139,514
Closed -$398K 499
2024
Q2
$398K Sell
139,514
-8,288
-6% -$23.6K 0.04% 267
2024
Q1
$627K Sell
147,802
-9,911
-6% -$42K 0.06% 233
2023
Q4
$844K Hold
157,713
0.09% 209
2023
Q3
$678K Sell
157,713
-9,607
-6% -$41.3K 0.08% 218
2023
Q2
$919K Buy
167,320
+38,000
+29% +$209K 0.1% 185
2023
Q1
$543K Hold
129,320
0.07% 240
2022
Q4
$358K Sell
129,320
-94,542
-42% -$262K 0.05% 293
2022
Q3
$573K Hold
223,862
0.1% 237
2022
Q2
$806K Sell
223,862
-44,604
-17% -$161K 0.2% 155
2022
Q1
$1.67M Hold
268,466
0.34% 69
2021
Q4
$1.89M Hold
268,466
0.39% 64
2021
Q3
$1.87M Buy
268,466
+69,498
+35% +$485K 0.41% 58
2021
Q2
$1.66M Buy
198,968
+33,829
+20% +$282K 0.3% 103
2021
Q1
$902K Buy
165,139
+26,706
+19% +$146K 0.16% 204
2020
Q4
$594K Buy
138,433
+17,978
+15% +$77.1K 0.13% 261
2020
Q3
$363K Sell
120,455
-8,875
-7% -$26.7K 0.1% 312
2020
Q2
$401K Buy
129,330
+26,099
+25% +$80.9K 0.1% 314
2020
Q1
$228K Buy
103,231
+80,303
+350% +$177K 0.07% 346
2019
Q4
$70K Hold
22,928
0.01% 441
2019
Q3
$71K Hold
22,928
0.02% 427
2019
Q2
$46K Buy
22,928
+7,128
+45% +$14.3K 0.01% 420
2019
Q1
$68K Hold
15,800
0.01% 412
2018
Q4
$50K Hold
15,800
0.01% 412
2018
Q3
$83K Buy
+15,800
New +$83K 0.02% 425
2015
Q4
Sell
-176,733
Closed -$668K 471
2015
Q3
$668K Hold
176,733
0.14% 250
2015
Q2
$1.01M Hold
176,733
0.18% 213
2015
Q1
$1.03M Sell
176,733
-59
-0% -$344 0.2% 215
2014
Q4
$1M Buy
+176,792
New +$1M 0.19% 216